Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis
- PMID: 35467405
- PMCID: PMC9248898
- DOI: 10.1128/spectrum.01692-21
Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis
Abstract
Leprosy is caused by Mycobacterium leprae and Mycobacterium lepromatosis. We report construction and analyses of the complete genome sequence of M. lepromatosis FJ924. The genome contained 3,271,694 nucleotides to encode 1,789 functional genes and 1,564 pseudogenes. It shared 1,420 genes and 885 pseudogenes (71.4%) with M. leprae but differed in 1,281 genes and pseudogenes (28.6%). In phylogeny, the leprosy bacilli started from a most recent common ancestor (MRCA) that diverged ~30 million years ago (Mya) from environmental organism Mycobacterium haemophilum. The MRCA then underwent reductive evolution with pseudogenization, gene loss, and chromosomal rearrangements. Analysis of the shared pseudogenes estimated the pseudogenization event ~14 Mya, shortly before species bifurcation. Afterwards, genomic changes occurred to lesser extent in each species. Like M. leprae, four major types of highly repetitive sequences were detected in M. lepromatosis, contributing to chromosomal rearrangements within and after MRCA. Variations in genes and copy numbers were noted, such as three copies of the gene encoding bifunctional diguanylate cyclase/phosphodiesterase in M. lepromatosis, but single copy in M. leprae; 6 genes encoding the TetR family transcriptional regulators in M. lepromatosis, but 11 such genes in M. leprae; presence of hemW gene in M. lepromatosis, but absence in M. leprae; and others. These variations likely aid unique pathogenesis, such as diffuse lepromatous leprosy associated with M. lepromatosis, while the shared genomic features should explain the common pathogenesis of dermatitis and neuritis in leprosy. Together, these findings and the genomic data of M. lepromatosis may facilitate future research and care for leprosy. IMPORTANCE Leprosy is a dreaded infection that still affects millions of people worldwide. Mycobacterium lepromatosis is a recently recognized cause in addition to the well-known Mycobacterium leprae. M. lepromatosis is likely specific for diffuse lepromatous leprosy, a severe form of the infection and endemic in Mexico. This study constructed and annotated the complete genome sequence of M. lepromatosis FJ924 and performed comparative genomic analyses with related mycobacteria. The results afford new and refined insights into the genome size, gene repertoire, pseudogenes, phylogenomic relationship, genome organization and plasticity, process and timing of reductive evolution, and genetic and proteomic basis for pathogenesis. The availability of the complete M. lepromatosis genome may prove to be useful for future research and care for the infection.
Keywords: Mycobacterium leprae; Mycobacterium lepromatosis; genomics; leprosy; reductive evolution.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis.Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4459-64. doi: 10.1073/pnas.1421504112. Epub 2015 Mar 23. Proc Natl Acad Sci U S A. 2015. PMID: 25831531 Free PMC article.
-
Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis.J Bacteriol. 2009 Oct;191(19):6067-74. doi: 10.1128/JB.00762-09. Epub 2009 Jul 24. J Bacteriol. 2009. PMID: 19633074 Free PMC article.
-
Mycobacterium leprae: pathogenic agent in leprosy. Discovery of new species Mycobacterium lepromatosis. Perspectives in research and diagnosis of leprosy.Int Marit Health. 2012;63(4):213-8. Int Marit Health. 2012. PMID: 24595978 Review.
-
The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.Int J Dermatol. 2012 Aug;51(8):952-9. doi: 10.1111/j.1365-4632.2011.05414.x. Int J Dermatol. 2012. PMID: 22788812 Free PMC article.
-
Identification of the leprosy agent Mycobacterium lepromatosis in Singapore.J Drugs Dermatol. 2012 Feb;11(2):168-72. J Drugs Dermatol. 2012. PMID: 22270197 Review.
Cited by
-
Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis.Emerg Infect Dis. 2023 Jul;29(7):1376-1385. doi: 10.3201/eid2907.230024. Emerg Infect Dis. 2023. PMID: 37347507 Free PMC article.
-
Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype.Front Microbiol. 2023 Jan 5;13:982679. doi: 10.3389/fmicb.2022.982679. eCollection 2022. Front Microbiol. 2023. PMID: 36687580 Free PMC article.
References
-
- Gelber RH. 2005. Leprosy (Hansen’s Disease). P 966–972. In Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (ed), Harrison’s principles of internal medicine, 16th ed McGraw-Hill, New York.
-
- Latapí F, Chevez Zamora A. 1948. The “spotted” leprosy of Lucio: an introduction to its clinical and histological study. Int J Lepr 16:421–430.
-
- Hansen GHA. 1874. Undersøgelser angående spedalskhedens årsager. Nor Mag Laegevidenskaben 9:1–88.
-
- Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007–1011. doi:10.1038/35059006. - DOI - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
